Jesper Lind
Business
Orexo
Sweden
Biography
Chief Operating Officer Holds current position since 2013. M.Sc., Royal Institute of Technology Stockholm, Sweden and Sydney University, Sydney, Australia. Previous appointments: Extensive senior global pharmaceutical manufacturing and supply chain experience from AstraZeneca, Pharmacia Biosensor and Alfa- Laval. Holds 2,000 shares and stock options entitled to 69,000, as of December 31 2016.
Research Interest
Interested in business
